SHPH insider filings
Shuttle Pharmaceuticals Holdings, Inc. — 27 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-07-15. Screen SHPH transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for SHPH between 2026-07-26 and 2026-10-24. The table below lists the most recent filings on record.
Recent insider filings — Shuttle Pharmaceuticals Holdings, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-15 | 4 | HRT FINANCIAL LP — 10% owner | Sale (S): 1,033 @ $4.67 · Sale (S): 82,116 @ $4.48 | EDGAR |
| 2026-07-13 | 4 | HRT FINANCIAL LP — 10% owner | Purchase (P): 8,266 @ $3.38 · Purchase (P): 731 @ $3.11 | EDGAR |
| 2026-07-09 | 4 | HRT FINANCIAL LP — 10% owner | Sale (S): 10,580 @ $3.33 · Sale (S): 18,531 @ $3.52 | EDGAR |
| 2026-07-07 | 4 | HRT FINANCIAL LP — 10% owner | Purchase (P): 7,851 @ $3.54 · Sale (S): 9,022 @ $3.51 | EDGAR |
| 2026-07-02 | 4 | HRT FINANCIAL LP — 10% owner | Purchase (P): 3,959 @ $3.30 | EDGAR |
| 2026-07-01 | 4 | HRT FINANCIAL LP — 10% owner | Purchase (P): 25,836 @ $3.44 · Purchase (P): 6,755 @ $3.23 | EDGAR |
| 2025-08-13 | 4 | Richards Steven M — Director | Grant/award (A): 29,240 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | Nabyt Oleh — Director | Grant/award (A): 29,240 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | Scorsis George — Director | Grant/award (A): 29,240 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | Tung Joseph — Director | Grant/award (A): 29,240 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | Lorber Timothy J. — Chief Financial Officer | Grant/award (A): 29,240 (derivative) @ $0 · Grant/award (A): 24,854 (derivative) @ $0 | EDGAR |
| 2024-10-09 | 4 | Jung Mira — Chief Scientific Officer | Grant/award (A): 598 @ $11.28 | EDGAR |
| 2024-03-14 | 4 | Senanayake Chris — Director | Sale (S): 1,626 @ $1.60 | EDGAR |
| 2024-03-08 | 4 | Vander Hoek Michael — Chief Financial Officer | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2024-01-02 | 4 | Brown Milton — Director | Sale (S): 2,921 @ $0.46 | EDGAR |
| 2023-12-20 | 4 | Jacobs Bette — Director | Sale (S): 4,157 @ $0.46 | EDGAR |
| 2023-08-18 | 4 | Dritschilo Anatoly — CEO and Chairman, Director, 10% owner | Gift (G): 2,100,000 @ $0 · Gift (G): 2,100,000 @ $0 | EDGAR |
| 2023-02-17 | 4 | Brown Milton — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-01-09 | 4 | Richards Steven M — Director | Sale (S): 995 @ $1.60 | EDGAR |
| 2023-01-04 | 4 | Adkins William | Sale (S): 995 @ $1.60 · Other (J): 138,889 (derivative) | EDGAR |
| 2023-01-04 | 4 | Brown Milton — Director | Sale (S): 995 @ $1.60 | EDGAR |
| 2023-01-03 | 4 | Dritschilo Anatoly — CEO and Chairman, Director, 10% owner | Sale (S): 8,372 @ $1.60 | EDGAR |
| 2023-01-03 | 4 | Rich Tyvin — Chief Medical Officer | Sale (S): 1,414 @ $1.60 | EDGAR |
| 2023-01-03 | 4 | Jung Mira — Chief Scientific Officer | Sale (S): 328 @ $1.60 | EDGAR |
| 2023-01-03 | 4 | Jacobs Bette — Director | Sale (S): 4,366 @ $1.60 | EDGAR |
| 2022-12-30 | 4 | Dritschilo Peter — President and COO | Sale (S): 3,820 @ $1.60 | EDGAR |
| 2022-12-30 | 4 | Vander Hoek Michael — Chief Financial Officer | Sale (S): 2,243 @ $1.60 | EDGAR |
Recent 8-K events — Shuttle Pharmaceuticals Holdings, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-22 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-24 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-28 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-17 | 8-K/A | 2.01 — Completion of Acquisition or Disposition of Assets 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SHPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs